Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques

被引:5
|
作者
Gao, Nan [1 ]
Gai, Yanxin [1 ]
Meng, Lina [1 ]
Wang, Chu [1 ]
Zhang, Xin [1 ]
Wang, Wei [2 ,3 ]
Qin, Chuan [2 ,3 ]
Yu, Xianghui [1 ,4 ]
Gao, Feng [1 ,5 ]
机构
[1] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China
[2] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China
[4] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130012, Peoples R China
[5] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源
VIRUSES-BASEL | 2020年 / 12卷 / 02期
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
simian; human immunodeficiency virus; neutralizing antibody; specificities; non-human primate; escape mutation; MONOCLONAL-ANTIBODIES; DEPENDENT EPITOPE; RHESUS MACAQUES; POTENT; RESPONSES; IDENTIFICATION; LINEAGES;
D O I
10.3390/v12020163
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Non-human primates (NHP) are the only animal model suitable to evaluate the protection efficacy of HIV-1 vaccines. It is important to understand how and when neutralizing antibodies (nAbs) with specificities similar to those of human broadly neutralizing antibodies (bnAbs) develop in NHPs. To address these questions, we determined plasma neutralization specificities in two macaques which developed neutralization breadth after long-term simian/human immunodeficiency virus (SHIV) infection and identified neutralization escape mutations by analyzing the env sequences from longitudinal plasma samples. Neutralization activities targeting V2, CD4bs, V3 and gp120-gp41 interface only became detectable in week 350 plasma from macaques G1015R and G1020R using 25710 env mutants. When mapped with CAP45 env mutants, only V2 specificity was detected at week 217 and persisted until week 350 in G1015R. Neutralization escape mutations were found in CD4bs and V2 regions. However, all of them were different from those resistant mutations identified for human bnAbs. These results show that nAbs with specificities similar to human bnAbs are only detectable after long-term SHIV infection and that neutralization escape mutations in macaques are different from those found in HIV-1-infected individuals. These findings can have important implications in the best utilization of the NHP model to evaluate HIV-1 vaccines.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques
    Shen, Xiaoying
    Bogers, Willy M.
    Yates, Nicole L.
    Ferrari, Guido
    Dey, Antu K.
    Williams, William T.
    Jaeger, Frederick H.
    Wiehe, Kevin
    Sawant, Sheetal
    Alam, S. Munir
    LaBranche, Celia C.
    Montefiori, David C.
    Martin, Loic
    Srivastava, Indresh
    Heeney, Jonathan
    Barnett, Susan W.
    Tomaras, Georgia D.
    JOURNAL OF VIROLOGY, 2017, 91 (19)
  • [22] Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas
    McCoy, L. E.
    Rutten, L.
    Dekkers, G.
    Blanchetot, C.
    Strokappe, N. M.
    Forsman-Quigley, A.
    Seaman, M. S.
    de Haard, H.
    Verrips, T.
    Weiss, R. A.
    RETROVIROLOGY, 2012, 9
  • [23] Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas
    LE McCoy
    L Rutten
    G Dekkers
    C Blanchetot
    NM Strokappe
    A Forsman-Quigley
    MS Seaman
    H de Haard
    T Verrips
    RA Weiss
    Retrovirology, 9
  • [24] Minimally Modified HIV-1 Infection of Macaques: Development, Utility, and Limitations of Current Models
    Sharma, Manish
    Nag, Mukta
    Del Prete, Gregory Q.
    VIRUSES-BASEL, 2024, 16 (10):
  • [25] Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection
    Saunders, Kevin O.
    Edwards, Robert J.
    Tilahun, Kedamawit
    Manne, Kartik
    Lu, Xiaozhi
    Cain, Derek W.
    Wiehe, Kevin
    Williams, Wilton B.
    Mansouri, Katayoun
    Hernandez, Giovanna E.
    Sutherland, Laura
    Scearce, Richard
    Parks, Robert
    Barr, Maggie
    DeMarco, Todd
    Eater, Chloe M.
    Eaton, Amanda
    Morton, Georgeanna
    Mildenberg, Benjamin
    Wang, Yunfei
    Rountree, R. Wes
    Tomai, Mark A.
    Fox, Christopher B.
    Moody, M. Anthony
    Alam, S. Munir
    Santra, Sampa
    Lewis, Mark G.
    Denny, Thomas N.
    Shaw, George M.
    Montefiori, David C.
    Acharya, Priyamvada
    Haynes, Barton F.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (661)
  • [26] A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
    Mothe, Beatriz
    Hu, Xintao
    Llano, Anuska
    Rosati, Margherita
    Olvera, Alex
    Kulkarni, Viraj
    Valentin, Antonio
    Alicea, Candido
    Pilkington, Guy R.
    Sardesai, Niranjan Y.
    Rocafort, Muntsa
    Crespo, Manel
    Carrillo, Jorge
    Marco, Andres
    Mullins, James I.
    Dorrell, Lucy
    Hanke, Tomas
    Clotet, Bonaventura
    Pavlakis, George N.
    Felber, Barbara K.
    Brander, Christian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [27] High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination
    Davis, Katie L.
    Gray, Elin S.
    Moore, Penny L.
    Decker, Julie M.
    Salomon, Aidy
    Montefiori, David C.
    Graham, Barney S.
    Keefer, Michael C.
    Pinter, Abraham
    Morris, Lynn
    Hahn, Beatrice H.
    Shaw, George M.
    VIROLOGY, 2009, 387 (02) : 414 - 426
  • [28] Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants
    Burton, Samantha
    Spicer, Lori M.
    Charles, Tysheena P.
    Gangadhara, Sailaja
    Reddy, Pradeep B. J.
    Styles, Tiffany M.
    Velu, Vijayakumar
    Kasturi, Sudhir Pai
    Legere, Traci
    Hunter, Eric
    Pillendran, Bali
    Amara, Rama
    Hraber, Peter
    Derdeyn, Cynthia A.
    JOURNAL OF VIROLOGY, 2019, 93 (07)
  • [29] Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
    Moore, Penny L.
    Gray, Elin S.
    Sheward, Daniel
    Madiga, Maphuti
    Ranchobe, Nthabeleng
    Lai, Zhong
    Honnen, William J.
    Nonyane, Molati
    Tumba, Nancy
    Hermanus, Tandile
    Sibeko, Sengeziwe
    Mlisana, Koleka
    Karim, Salim S. Abdool
    Williamson, Carolyn
    Pinter, Abraham
    Morris, Lynn
    JOURNAL OF VIROLOGY, 2011, 85 (07) : 3128 - 3141
  • [30] Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
    Lakhashe, Samir K.
    Amacker, Mario
    Hariraju, Dinesh
    Vyas, Hemant K.
    Morrison, Kyle S.
    Weiner, Joshua A.
    Ackerman, Margaret E.
    Roy, Vicky
    Alter, Galit
    Ferrari, Guido
    Montefiori, David C.
    Tomaras, Georgia D.
    Sawant, Sheetal
    Yates, Nicole L.
    Gast, Chris
    Fleury, Sylvain
    Ruprecht, Ruth M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13